Educational Activities Archives

Join this 1.5‑hour live virtual session to delve into the emerging prevalence of medetomidine within the drug supply and strategies to manage medetomidine-opioid withdrawal syndrome. Participants will explore real‑world scenarios through case examples presented by addiction experts, applying key concepts to clinical practice.

Join this 1.5‑hour live virtual session to learn about common conditions that complicate opioid withdrawal management in emergency department and hospital settings. The session will address co‑occurring medical and psychiatric conditions and provide practical strategies for managing complex withdrawal cases. Participants will explore real‑world scenarios through case examples led by addiction experts, applying key concepts to clinical practice.

Understanding addiction is essential to successfully addressing it. In this overview of substance use disorders, we discuss the spectrum of use, neurobiological responses to substances, theories that explain the disorders, public health impact and epidemiology, comorbidity, and integrated care for this chronic condition.

Patient-centered care has become a crucial approach when working with patients with substance use disorder (SUD). Unfortunately, the care continuum can be interrupted for patients with SUDs, often due to stigma and discrimination. Each interruption increases challenges in access to care and can lead to patient harm. Language can intentionally or unintentionally perpetuate stigma. As people who care for patients with SUDs, we need to learn their rights so we can advocate for them and change our language to reduce stigma. This course will discuss the importance of patient-centered care, improved language when discussing substance use, and advocacy strategies that clinicians can use when caring for people who use substances.

Unhealthy substance use and substance use disorders may often go unrecognized in primary care settings, either due to insufficient screening or provider discomfort with how to manage a positive screening. There are brief, simple, validated screening tools and strategies that can provide information to indicate unhealthy substance use or the possible presence of a substance use disorder. This information can inform providers whether a simple brief intervention or a referral to treatment is warranted. This course will: introduce screening tools for alcohol and other drug use; review more detailed substance use, medical, and psychiatric assessment considerations; demonstrate effective strategies for brief interventions; and discuss considerations for treatment referrals.

Opioid use disorder (OUD) has highly effective FDA-approved medications for its treatment. This course reviews and compares pharmacological treatment options for individuals with OUD, including methadone, buprenorphine (sublingual and injectable formulations), and naltrexone (oral and long-acting intramuscular formulations). Current evidence for each medication is reviewed in detail, and studies comparing each are discussed. The purpose and goal of medications for OUD are reviewed, and different treatment models are presented. The course includes case vignettes in which medication options for OUD are considered.